BRKR News and Press, Bruker Corporation

2024-06-27 08:24:25 ET Summary Agilent's may be an underappreciated winner with Alnylam's recent clinical success, as manufacturing Amvuttra could generate more than $500M in revenue in the coming 5-7 years that isn't in models. Sharp cutbacks in capex spending across academic lab...

2024-06-20 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

timsTOF Ultra 2 enables significant further improvements in deep, high-fidelity 4D-Proteomics™ of mammalian cells, cancer cell lines, or tissue biopsies With sensitivity to measure >1000 proteins on just 25 pg, the timsTOF Ultra 2 opens new cell and disease biology research ...

neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam 3D laser neofleX and MALDI HiPLEX-IHC technology enable protein tissue im...

The Bruker Applied Mass Spectrometry Division is showcasing some of its latest innovations at ASMS 2024: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240603585315/en/ EVOQ® DART-TQ⁺ mass spectrometer: A ...

2024-05-31 15:23:59 ET Summary Bruker Corporation is a life science research and diagnostics firm which has seen a solid 2023. The company pursued an aggressive acquisition strategy this year, raising questions about the impact on sales, earnings, and debt. With the pro forma ...

The proprietary P2 Plasma Enrichment method leverages a novel single-well, single particle-type enrichment method to achieve market-leading performance for unbiased, deep mass spectrometry-based plasma proteomics P2 now offers excellent quantitation and higher throughput for large-cohort ...

Spectronaut ® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery ® P2 Plasma Enrichment method offers market-leading performance and superior economics for unbi...

2024-05-30 08:25:46 ET Maxeon Solar Technologies MAXN -61% after reports mixed Q1 results; initiates Q2 and FY24 outlook . UiPath PATH -29% despite upbeat Q1 results , UiPath's shares plummeted, overshadowed by the announcement of CEO Rob Enslin's resi...

Bruker Corporation (“Bruker” or the “Company”) (Nasdaq: BRKR) today announced the pricing of its previously announced underwritten registered public offering of 6,000,000 shares of its common stock. Additionally, the Company has granted the underwriters a 30-day opti...